Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

E-Interventions to Treat Fear of Cancer Recurrence for Patients With Localized Renal Cell Carcinoma

NCT04688333 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT04688333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04688333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
E-Interventions to Treat Fear of Cancer Recurrence for Patients With Localized Renal Cell Carcinoma
Lead sponsor
City of Hope Medical Center
Phase
Observational
Overall status
Withdrawn
Start date
August 20, 2022
Completion date
August 27, 2023
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

renal cell carcinoma